Description
Recent outbreaks of Zika virus (ZIKV) highlight the urgent need to develop efficacious interventions against flaviviruses, many of which cause devastating epidemics around the world. Monoclonal antibodies (mAb) have been at the forefront of treatment for cancer and a wide array of other diseases due to their specificity and potency.
Copyright Statement
Reuse Permissions
Download count: 0
Details
Contributors
- Sun, Haiyan (Author)
- Chen, Qiang (Author)
- Lai, Huafang (Author)
- Biodesign Institute (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2017-12-25
Resource Type
Collections this item is in
Identifier
- Digital object identifier: 10.3390/ijms19010054
- Identifier TypeInternational standard serial numberIdentifier Value1661-6596
- Identifier TypeInternational standard serial numberIdentifier Value1422-0067
Citation and reuse
Cite this item
This is a suggested citation. Consult the appropriate style guide for specific citation guidelines.
Sun, H., Chen, Q., & Lai, H. (2017). Development of Antibody Therapeutics against Flaviviruses. International Journal of Molecular Sciences, 19(1), 54. doi:10.3390/ijms19010054